Cell and gene therapy in experimental models in Alzheimer’s disease

Team of work

Principal InvestigatorReggiani

Reggiani, Paula Cecilia

Investigator
paulareggiani@conicet.gov.ar

Morel, Gustavo RamónMorel

Investigator
gustavmorel@med.unlp.edu.ar

Pardo, JoaquínPardo

Investigator
joaquinpardo@med.unlp.edu.ar

Peralta, FacundoPeralta

Research Fellow
facundoperaltaunlp@gmail.com

Vidal Escobedo, Ana AbrilVidal

Research Fellow
aabrilv@hotmail.com.ar

Collaborators from other institutions

Ferreira, Sergio T.
Instituto de Bioquímica Médica Biofísica Leopoldo de Meis. Profesor de Biofísica, Bioquímica y Neurociencias en el Instituto de Biofísica Carlos Chagas Filho (IBCCF) e Instituto de Bioquímica Médica Biofísica Leopoldo de Meis. Universidad Federal de Rio de Janeiro, Rio de Janeiro, Brasil.

Ogundele, Olalekan Michael.
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.

García, Mariana
Hospital Austral, Universidad Austral, Pilar. Provincia de Buenos Aires.

Hereñú, Claudia B.
IFEC- Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba.

Line overview

Alzheimer’s disease (AD) is the most common neurodegenerative pathology, affecting over 40 million people all over the world (Alzheimer’s Association, 2015). This disease is characterized by a progressive memory deficit, cognitive impairment, and personality changes, and it is accompanied by a reduction in the use of glucose and brain energy metabolism, the formation of neuritic plaques, and intraneuronal neurofibrillary tangles, and a progressive neuronal degeneration. Also it is known that neuroinflammation plays a crucial role in this neuropathology, and that soluble oligomers of amiloid-β (Aβ) peptide or ADDLs (Aβ-derived diffusible ligands) are the main neurotoxins associated to an early synaptic dysfunction and oxidative stress. Unfortunately, there is no available treatment that may cure or prevent neuronal death resulting in the inevitable impairment in patients with AD.
Our general objective is the development of advanced therapeutic strategies that allows preventing and/or compensating for the degenerative changes occurring in the brain with experimental Alzheimer. In this context, gene therapy, cell therapy and the use of potent neuroprotective molecules, such as insulin-like growth factor I (IGF-I) and glial cell-derived neurotrophic factor (GDNF), and anti-inflammatory molecules such as thymic thymulin peptide emerge as promising therapeutic approaches.
n the last years we developed a set of biotechnological tools that allows generating adjustable, bicistronic, simple and adenoviral vectors, of first and latest technology for diverse trophic factors, and, more recently, we entered into the technology of messenchymal stem cells (MSC).
Also we have recently tuned up in the laboratory an AD model in rats and a series of cognitive tests that enable us to evaluate the anxiety-like behavior, depression and memory of object recognition. Briefly, in the in vivo AD model, animals are injected intracerebrally with a diabetogenic drug, streptozotocin (STZ), what triggers progressive cognitive impairment with learning and spatial memory deficit, brain insulin resistance, insulin impairment, increase of oxidative stress mitochondrial dysfunction and neurodegeneration, all anomalies similar to those observed in AD.
In this animal model and in primary cultures of hippocampal neurons treated with ADDLs (an in vitro AD model), we try to evaluate the anti-inflammatory and neuroprotective potential of gene transfer of IGF-I, GDNF, and thymulin, and of naive MSC transfer, or the overexpression of some of the mentioned factors.

Streptozotocin‐induced sporadic Alzheimer's disease: Behavioral effects in female rats.
Villar, Maria Florencia Zappa; Hanotte, Juliette López; Peralta, Facundo; Reggiani, Paula Cecilia
2022. Alzheimers & dementia. ELSEVIER SCIENCE INC, 2022 - vol. 17, n° S3, ISSN 1552-5260
doi.org/10.1002/alz.051339

Insulin-Like Growth Factor 1 gene transfer for sporadic Alzheimer’s Disease: new evidence for trophic factor mediated hippocampal neuronal and synaptic recovery-based behavior improvement.
Zappa Villar, M. F; López Hanotte, J; Crespo, R; Pardo, J; Reggiani, P. C.
2021. Hippocampus 202
doi.org/10.1002/hipo.23379

Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model.
Sellés, M. C; Fortuna, J. T. S; Zappa-Villar, M. F; de Faria, Y. P. R; de Souza, A. S; Suemoto, C. K; Leite, R. E. P; Rodríguez, R. D; Grinberg, L. T; Reggiani, P.C; Ferreira, S. T.
2020. Mol Neurobiol. 2020 Mar;57(3):1473-1483
doi.org/10.1007/s12035-019-01827-y

Intracerebroventricular Delivery of Human Umbilical Cord Mesenchymal Stem Cells as a Promising Therapy for Repairing the Spinal Cord Injury Induced by Kainic Acid.
Nishida, Fabián; Zappa Villar, María F; Zanuzzi, Carolina N; Sisti, María S; Camiña, Agustina E; Reggiani, Paula C; Portiansky, Enrique L.
2020. Stem cell reviews and reports. HEIDELBERG: SPRINGER HEIDELBERG, vol. 16, p. 167-180. ISSN 1550-8943
doi.org/10.1007/s12015-019-09934-y#Abs1

Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats.
Zappa Villar; M. F; López Hanotte, J, Pardo, J; Morel, G. R; Mazzolini, G; García, M. G; Reggiani, P. C.
2019. Molecular Neurobiology.
doi.org/10.1007/s12035-019-01729-z

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin- Embedded 3D Glioma Neurosphere Cultures.
Núñez F; Mendez F; Garcia Fabbiani M. B; Pardo, Joaquín; Edwards M; Lowenstein P. R; Castro M. G.
2019: Journal of visualized experiments. MYJoVE Corporation. ISSN 1940-087X
doi: 10.3791/58931

Regulatable adenovector harboring the GFP and Yamanaka genes for implementing regenerative medicine in the brain.
Lehmann, M; Canatelli-Mallat, M; Chiavellini, P; Morel, G. R; Reggiani, P. C; Hereñú, C. B; Goya, R. G.
2019. Gene Therapy.
doi.org/10.1038/s41434-019-0063-x

Umbilical Cord Cell Therapy Improves Spatial Memory in Aging Rats.
Lehmann, M; Zappa-Villar, M. F; García, M. G; Mazzolini, G; Canatelli-Mallat, M; Morel, G. R; Reggiani, P. C; Goya, R. G.
2019. Stem Cell Reviews and Reports.
doi.org/10.1007/s12015-019-09895-2

Intracerebroventricular streptozotocin induces impaired Barnes maze spatial memory and reduces astrocyte branching in the CA1 and CA3 hippocampal regions.
Zappa Villar, M. F; López Hanotte, J; Falomir Lockhart, E; Trípodi, L. S; Morel, G. R; Reggiani, P. C.
2018. Journal of neural transmission. General section. SPRINGER WIEN, vol. 125, n° 12, p. 1787-1803. ISSN 0300-9564

Identification of a conserved gene signature associated with an exacerbated inflammatory environment in the hippocampus of aging rats.
Pardo, J; Abba, M. C; Lacunza, E; Francelle, L; Morel, G. R; Outeiro, T. F; Goya, R. G.
2017. Hippocampus. Apr;27(4):435-449. Doi: 10.1002/hipo.22703 Epub 2017 Jan 23. PubMed PMID: 28085212

Long-lasting training in the Barnes maze prompts hippocampal spinogenesis and habituation in rats.
Uriarte, M; Ogundele, O. M; Pardo, J.
2017. Neuroreport. Apr 12;28(6):307-312. Doi: 10.1097/WNR.0000000000000755 PubMed PMID: 28225479

Therapeutic potential of igfi gene therapy on spatial memory and hippocampal neurogenesis during aging.
Morel, G. R; López León, Micaela; Uriarte, M; Reggiani, P. C; Goya, R, G.
2017. Neurogenesis. Philadelphia: Taylor & Francis, Group. vol. 4, ISSN 2326-2133

A new adenovector system for implementing thymulin gene therapy for inflammatory disorders.
Zappa-Villar, M. F; López-León, M; Pardo, J; Costa, M; Crespo, R; Dardenne, M; Goya, R. G; Reggiani, P. C.
2017. Molecular immunology: PERGAMON-ELSEVIER SCIENCE LTD. vol. 87, p. 180-187. ISSN 0161-5890

Racemized and isomerized proteins in aging rat teeth and eyelens. Rejuvenation research.
Warmack, R; Mansilla, E; Goya, R. G; Clarke, S. G.
2016. New York: MARY ANN LIEBERT INC, vol. 19, n° 4, p. 309-317. ISSN 1549-168

Therapeutic potential ofigf-i on hippocampal neurogenesis and function during aging.
Morel, G. R; Lopez-León, M; Uriarte Donati, M; Reggiani, P. C; Goya, R. G.
2016. Neurogenesis, Austin (Texas): London: Taylor & Francis Group, LLC, vol. 4, n° 1, ISSN 2326-2133

Stress-induced Gene Expression Sensing Intracellular HeatingTriggered by Magnetic Hyperthermia.
De Sousa, M. E; Carrea, A; Mendoza Zélis, P; Muraca, D; Mykhaylyk, O; Sosa, Y. E; Goya, R. G; Sánchez, F. A; Dewey, R; Fernández Van Raap, M. B.
2016. Journal of Physical Chemistry c. Washington: Amer Chemical Soc, vol. 120, p. 7339-7348. ISSN 1932-7447

Magnetofection enhances adenoviral vector-based gene delivery in skeletal muscle cells.
Pereyra, A. S; Mykhaylyk, O; Falomir Lockhart, E; Taylor, J. R; Delbono, O; Goya, R. G; Plank, C; Hereñu, C. B.
2016. J Nanomed Nanotechnology: OMICS International, vol. 7, n° 2, ISSN 2157-7439

A rat treated with mesenchymal stem cells livesto 44 months of age.
Mansilla. E; Roque. G; Sosa. Y. E; Tarditti, A; Goya, R. G.
2016. Rejuvenation Research. New York: MARY ANN LIEBERT INC, vol. 19, n° 4, p. 318-321. ISSN 1549-1684

Insulin-like growth factor-I gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats.
Pardo, J; Uriarte, M; Cónsole, G. M; Reggiani, P; Outeiro, T. F; Morel, G. R; Goya, R. G.
2016. Eur J Neurosci. Aug;44(4):2120-8. Doi: 10.1111/ejn.13278 Epub 2016 Jun 8. PubMed PMID: 27188415

Calpain inhibition rescues troponin T3 fragmentation, increases Cav1.1 and enhances skeletal muscle force in aging sedentary mice.
Zhang, T; Pereyra, A. S; Wang, Z. M; Birbrair, A; Reisz, J. A; Files, C. D; Purcell, L; Feng, X; Messi, M. L; Feng, H; Chalovich, J; Jin, J-P; Furdui, C; Delbono, O.
2016. Aging Cell. 2016 Feb 19. doi: 10.1111/acel.12453

Troponin T3 regulates nuclear localization of the calcium channel CavB1a subunit in skeletal muscle.
Zhang, T; Taylor, J; Jiang, Y; Pereyra, A. S; Messi, M; Wang, Z. M; Hereñú, C; Delbono, O.
2015. Experimental Cell Research. 2015 May 15; 336 (2): 276-286

Therapeutic exercise attenuates neutrophilic lung injury and skeletal muscle wasting.
D. Clark Files; Liu, C; Pereyra, A. S; Zhong-Min Wang; Aggarwal, N; D´Alessio, F; Delbono, O.
2015. Science Translational Medicine. Washington: American Association for the Advancement of Science, vol. 7, n° 278, p. 278-310. ISSN 1946-6234

Cognitive impairment and morphological changes in the dorsal hippocampus of very old female rats.
Morel, G; Andersen, T; Pardo, J; Zucolilli, G. O; Cambiaggi, V. L; Hereñú, C; Goya, R. G.
2015. Neuroscience. Amsterdam: PERGAMON-ELSEVIER SCIENCE LTD, p. 189-199. ISSN 0306-4522

Regional research priorities in brain and nervous system disorders.
Ravindranath, V; Dang, H. M; Goya, R. G; Mansour, H; Nimgaonkar, V. L; Russell, V. A; Xin, Y.
2015. Nature, 527: S198–S206

Estrogen actions on glial reactivity and inflammation-mediated memory impairment: Sex differences and interaction with other neurotrophic factors.
Bellini, M. J.
2015. González-Burgos (Ed.); Nova Science Publishers, July 01, 2015, Pages 155-174

Neuroprotective gene therapy in the aging brain.
Pardo, J; Morel, G. R; Pereyra, A. S; López-León, M; Brown-O. A, Bellini, M. J; Goya, R. G.
2014. Estrogens and Cognition. Psycho-biological and Clinical Aspects: González-Burgos (Ed.) ISBN: 978-81-308-0550-4; pp.97-117

Therapeutic potential of the thymic peptide thymulin.
Reggiani, P. C; Schwerdt, J. I; Cónsole, G. M; Roggero, E; Dardenne, M; Goya, R. G.
2014. Current Pharmaceutical Design, 20: 4690-4696

Physiology and therapeutic potential of the thymic peptide thymulin.
Reggiani, P. C; Schwerdt, J. I; Console, G. M; Roggero, E. A; Dardenne, M; Goya, R. G.
2014. Current Pharmaceutical Design. Oak Park: BENTHAM SCIENCE PUBL LTD, vol. 20, n° 29, p. 4690-4696. ISSN 1381-6128

Regenerative Medicine for the Aging Brain.
Lopez Leon, M; Reggiani, P; Hereñú, C; Goya, R.
2014. Herbert Publication. vol. 1, n° 1, p. 1-9. ISSN 2050-1218.Enliven J Stem Cell Res Regen Med.

The Cavβ1a subunit regulates gene expression and suppresses myogenin in muscle progenitor cells.
Taylor, J; Pereyra, A. S; Zhang, T; Messi, M. L; Zhong-Min Wang; Hereñú, C; Pei-Fen Kuan; Delbono, O.
2014. Journal of Cell Biology. New York: ROCKEFELLER UNIV PRESS,.vol. 205, n° 6, p. 829-846. ISSN 0021-9525

DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma.
Da Silva, A.L; Martini, S. V; Abreu, S.C; Samary, C. D; Diaz, B. L; Fernezlian S de Sá, V. K; Capelozzi, V. L; Boylan, N. J; Goya, R. G; Suk, J. S; Rocco, P. R; Hanes, J; Morales, M. M.
2014. Journal of Controlled Release. Amsterdam: ELSEVIER SCIENCE BV. vol. 180, p. 125-133. ISSN 0168-3659

Gene therapy and cell reprogramming for the aging brain: achievements and promise.
Pardo, J; Morel, G. R; Astiz, M; Schwerdt, M. I; López León, M; Rodríguez, S. S;Hereñú, C. B; Goya, R. G.
2014. Curr Gene Ther; 14:24-34

Transferencia génica asistida por campos magnéticos: estudios en células gliales.
Pardo, J; Sosa, Y; Reggiani, P. C; Arciniegas, M. L; Sánchez, F; Goya, R. G.
2013. Acta Bioquímica Clínica Latinoamericana. La Plata: Federacion Bioquímica Provincia Buenos Aires, vol. 47, n° 2, p. 399-406. ISSN 0325-2957

The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies.
Martines, E. V; Reggiani, P. C; Camihort, G; Luna, G; Zappa, M. F; Brown, O. A; Goya, R. G; Cónsole, G. M.
2013. Neuroimmunomodulation. Basel: Karger. vol. 20, p. 256-263. ISSN 1021-7401

Hypothalamic insulin-like growth factor-I gene therapy prolongs estral cyclicity and protects ovarian structure in middle-aged female rats.
Rodriguez, S. S; Schwerdt, J. I; Barbeito, C. G; Flamini, A. M; Han, Y; Bohn, M. C; Goya, R. G.
2013. Endocrinology.Bethesda: Endocrine Soc. vol. 154, n° 6, p. 2166-2173. ISSN 0013-7227

Magnetic field-assisted gene transfer: Studies in glial cells (in Spanish).
Pardo, J; Sosa, Y. E; Reggiani, P. C; Arciniegas, M. L; Sánchez, F; Goya, R. G.
2013. Acta Bioquímica Latinoamericana; 47: 399-406

Role of copper and cholesterol association in the neurodegenerative process.
Arnal, N; Morel, G. R; Tacconi de Alaniz, M. J; Dominici, L; Marra, C. A.
2013. Int J Alzheimers Dis; 2013:414817. doi: 10.1155/2013/414817. Epub 2013 Oct 29

Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-α and -β.
Grassi, D; Bellini, M. J; Acaz-Fonseca, E; Panzica, G; Garcia-Segura, L. M.
2013. Endocrinology. 154: 2092-100

Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice.
Diz-Chaves, Y; Astiz, M; Bellini, M. J; Garcia-Segura, L. M.
2013. Brain Behavior and Immunity. Amsterdam: Academic Press Inc Elsevier Science. vol. 28, p. 196-206. ISSN 0889-1591

Magnetic field-assisted gene delivery: achievements and therapeutic potential.
Schwerdt, J. I; Goya, G. F; Calatayud, P; Hereñu, C; Reggiani, P. C; Goya, R. G.
2012. Current gene therapy. Oak Park: Bentham Science Public Ltd, vol. 12,n° 1, p. 116-126

Neonatal thymulin gene therapy prevents ovarian dysgenesis and attenuates reproductive derangements in nude female mice.
Reggiani, P. C; Barbeito, C. G; Zuccolilli, G. O; Cónsole, G. M; Flamini, A. M; Dardenne, M; Goya, R. G.
2012. Endocrinology: Endocrine Soc, vol. 153, n° 8, p. 3922-3928

Role of thymulin on the somatotropic axis in vivo.
Reggiani, P.C; Martinez, E; Camihort, G.A; Poch, B; Goya, R. G; Console, G. M.
2012. Life Sciences, Amsterdam: Pergamon - ElSevier Science Ltd, vol. 91, p. 166-171

Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis.
Escudero-Vilaplana, V; Ramírez-Herraiz, E; Trovato-López, N; Alañón-Plaza, E; Bellini, M; Herranzalonso, A; Bellón-Cano, J.M; Morell-Baladrón, A; Sanjurjo-Sáez, M.
2012. Journal of pharmacy and pharmaceutical sciences: Canadian Soc Pharmaceutical Sciences, vol. 15, n° 3, p. 355-360

Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.
Arevalo, M.A; Diz-Chaves, Y; Santos-Galindo, M; Bellini, M.J; Garcia-Segura, L. M.
2012. Journal of neuroendocrinology. Oxford: Wiley-Blackwell Publishing, Inc, vol. 24, p. 183-190

Increased romatase expression in the hippocampus of spontaneously hypertensive rats: effects of estradiol administration.
Pietranera, L; Bellini, M. J; Arévalo, M. A; Goya, R; Brocca, M. E; García Segura, L. M; De Nicola, A. F.
2011. Neuroscience, 174: p. 151-159

Cytotoxic and genotoxic effects of defence secretion of Ulomoides dermestoides on A549 cells.
Reggiani, P. C; Poch, B; Cónsole, G. M; Rimoldi, O. J; Schwerdt, J. I; Tüngler, V; García-Bravo, M. M; Dardenne, M; Goya, R. G.
2011. J Ethnopharmacol 136, 204–209. Editorial: Elsevier.

Increased number of neurons in the cervical spinal cord of aged female rats.
Portiansky, E. L; Nishida, F; Barbeito, C. G; Gimeno, E. J; Goya, R. G.
2011. PloS One, 6: e22537

Insulin-like growth factor I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide.
Bellini, M. J; Hereñú, C. B; Goya, R. G; García Segura, L. M.
2011. Neuroinflammation, 8: 21

Restorative effect of intracerebroventricular Insulin-like Growth Factor-I gene therapy on motor performance in aging rats.
Nishida, F; Morel, G. R; Hereñú, C. B; Schwerdt, J. I; Goya, R. G; Portiansky, E. L.
2011. Neuroscience, 177: 195 - 206

Thymulin-based gene therapy and pituitary function in animal models of aging.
Reggiani, P. C; Poch, B; Cónsole, M. G; Rimoldi, O. J; Schwerdt, J. I; Tüngler, V; García de Bravo, M. M; Dardenne, M; Goya, R. G.
2011. Neuroimmuno-modulation, 18: 350-356

Morphological effects on the corticotrope population by thymulin gene therapy in nude mice.
Martinez, E. V; Reggiani, P. C; Schwerdt, J. I; Goya, R. G; Cónsole, G. M.
2011. Histology and Histopathology; 26: 471-479

Thymulin gene therapy prevents the histomorphometric changes induced by thymulin deficiency in the thyrotrope population of mice.
Martinez, E. V; Reggiani, P. C; Schwerdt, J. I; Goya, R. G; Cónsole, G. M.
2011. Cells, Tissues, Organs, 194: 67-75

Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior; adult mice: a potential model of geriatric depression.
Mitschelen, M; Yan, H; Farley, J. A; Warrington, J. P; Han, S; Hereñú, C. B; Csiszar, A; Ungvari, Z; Bailey-Downs, L. C; Bass, C. E; Sonntag, W. E.
2011. Neuroscience; 185: 50 - 60

Morphological changes induced by insulin-like growth factor-I gene therapy in pituitary cell populations in experimental prolactinomas.
Camihort, G. A; Hereñú, C. B; Luna, G. C; Rodríguez, S. S; Bracamonte, M. I; Goya, R. G; Cónsole, G. M.
2010. Cells tissues organs. Karger. vol. 191, p. 316-325

Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats.
Morel, G. R; Sosa, Y. E; Bellini, M. J; Carri, N. G; Rodriguez, S, S; Bohn, M. C; Goya, R.
2010. Neuroscience; vol. 167 p. 946 - 953

Decrease in PTEN and increase in Akt expression and neuron size in aged rat spinal cord.
Rodríguez de Amorim, M. A; García-Segura, L. M; Goya, R, G; Portiansky, E. L.
2010. Experimental gerontology. Pergamon-Elsevier Science Ltd. vol. 45, p. 457-463

Carbohydrates and glycoforms of the major egg perivitellins from Pomacea apple snails (Architaenioglossa: Ampullariidae).
Morel, G; Sosa, Y. E; Bellini, M. J; Carri, N. G; Rodriguez, S; Bohn, M. C; Goya, R. G.
2010. Neuroscience. Pergamon-Elsevier Science Ltd. vol. 167, p. 946-953

The ependymal route for insulin-like growth factor-1 gene therapy in the brain.
Hereñu C. B; Sonntag W.E; Morel G. R; Portiansky E. L; Goya R. G.
2009. Neuroscience. Elsevier, vol. 163, p. 442-447

Morphological Restoration of Gonadotrope Population by Thymulin Gene Therapy in Nude Mice.
Reggiani P; Martínez E; Ferese C; Goya R; Cónsole G.
2009. Histology and Histopathology. Murcia, Spain: Gutenberg, vol. 24 nº 6, p.729-735

The thymus-neuroendocrine axis: physiology, molecular biology and therapeutic potential of the thymic peptide thymulin.
Console, G. M; Hereñu, C. B; Camihort, G. A; Luna, G. C; Bracamonte, M. I; Morel, G. R; Goya, R. G.
Reggiani P.C; Morel G. R; Cónsole G. M; Barbeito C. G; Rodriguez S; Brown O. A; Bellini M. J; Pléau J. M; Dardenne M; Goya R. G.
2009. Annals of the New York Academy of Sciences. New York: New York Academy of Sciences. Blackwell Publishing, vol. 1153, p. 98-106

Effect of insulin-like growth factor- I gene therapy on the somatotropic axis in experimental prolactinomas.
Console G.M; Hereñú C. B; Camihort G. A; Luna G. C; Ferese C; Goya R.G.
2009. Cells Tissues Organs. Basel: Karger AG, vol. 190, p. 20-26

Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage.
Morel, G. R; Caron, R. W; Console, G. M; Soaje, M; Sosa, Y. E; Rodríguez, S. S; Jahn, G. A; Goya, R. G.
2009. Brain Research Bulletin. Amsterdam: Elsevier, vol. 80, n° 6, p. 347-352

Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas.
Console, G. M; Hereñu, C. B; Camihort, G. A; Luna, G. C; Bracamonte, M. I; Morel, G. R; Goya, R. G.
2008. Molecular cancer. Londres: Blackwell Scientific Publications, p. 7-13

Dopaminergic mesencephalic systems and motor performance in very old rats.
Sánchez, H. L; Silva, L. B; Portiansky, E. L; Hereñu, C. B; Goya, R. G.
2008. Neuroscience. USA: Elsevier, vol. 154, n° 4, p. 1598-1606

Preventive action of neonatal gene therapy with the thymic hormone thymulin on the ovarian atrophy of adult nude mice.
Reggiani, P.C; Flamini, M. A; Rodriguez, S. S; Goya, R. G; Barbeito, C. G.
2008. Biocell. Mendoza: IHEM-CONICET, vol. 32, p. 137-137

Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.
Morel, G. R; Reggiani, P. C; Cónsole, G. M; Rimoldi, O. J; Vesenbeckh, S. M; García De Bravo, M; Rodríguez, S. S; Brown, O. A; Goya, R. G.
2008.Curr gene ther. Bentham Science Publishers, vol. 8 n° 1 p.49-53 ISSN 1566-5232

Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.
Morel G. R; Reggiani P. C; Console, G. M; Rimoldi, O. J; Vesenbeckh, S. M; Garcia De Bravo M. M; Rodriguez, S. S; Brown, O. A; Goya, R. G.
2007. Curr gene ther... vol. 8, p. 49-53

PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina, C; Diaz Torga, G; Goya, R. G; Kakar, S. S; Perez Millan, M. I; Giannella Neto, D; Bronstein, M. D; Becu Villalobos, D.
2007. Molecular cancer. Inglaterra: BMC. vol. 6, p. 4-9

Fatty acid profiles in hepatic membranes of rats with different levels of circulating estrogen and prolactin.
Bellini, M. J; Carino, M; Tacconi de Gomez Dumm, I. N; Goya, R. G.
2007. Comparative biochemistry and physiology molecular and integrative physiology. USA: Elsevier. vol. 146, p. 470-474

Restorative effect of Insulin-like Growth Factor-I Gene Therapy in the Hypothalamus ofsenile rats with Dopaminergic dysfunction.
Hereñu, C. B; Cristina, C; Rimoldi, O. J; Becu-Villalobos, S; Cambiaggi, V; Portiansky, E. L; Goya, R. G.
2007. Gene therapy. Nature Publishing Group. vol. 14, p. 237-245. ISSN 0969-7128

Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.
Goya, R. G; Reggiani, P. C; Vesenbeckh, S. M; Pleau, J. M; Sosa, Y. E; Console, G. M; Schade, R; Henklein, P; Dardenne, M.
2007. American journal of physiology-endocrinology and metabolism. American Physiological Society. vol. 293, p. 182-187

Logros y promesas de la medicina regenerativa en el tratamiento de enfermedades neurodegenerativas.
López-León, M; Lehmann, M; Goya, R. G.
2016. Universidad de Murcia (Master); 6º Ed.; Viguera Editores SLU; Barcelona; 2016. Capítulo en el libro “Desordenes del Movimientro”.

Medicina regenerativa para el tratamiento de enfermedades nuerodegenerativas.
López-León, M: Goya, R. G.
2015. Universidad de Murcia (Master); 5º Ed.; Viguera Editores SLU; Barcelona. Capítulo en el libro “Desordenes del Movimientro”

Gene Delivery Systems.
Pereyra, A. S; Hereñu, C. B.; Romanovsky, V; Zgela, V; Bakic, S.
2013. Editorial InTech, p. 165-192. ISBN 978-953-51-1207-5

Neuroendocrine system and aging: growth hormone, thyroid stimulating hormone, prolactin and insulin.
Sonntag William, E; Hereñú, C. B; Goya, R. G.
2008. New York. New Encyclopedia of Neuroscience

Neuroendocrine Aging: Pituitary-metabolism.
Sonntag W. E; Hereñú, C. B.
2006. New Encyclopedia of Neuroscience; p. 1-18

Premio al mejor trabajo en investigación básica en el 2º Congreso Internacional de la Facultad de Cs Médicas de la UNLP.
Trabajo: Pardo, J; Abba, M; Lacunza, E; Schwerdt, J; Cónsole, G; Outeiro, T; Morel, G; Goya, R. “Expresión génica diferencial de hipocampo en un modelo de envejecimiento cerebral tratado con terapia génica de largo plazo”. Presentación oral. Noviembre 2015.

Distinción otorgada al trabajo científico: “Transferencia génica asistida por campos magnéticos: estudios en células gliales”. Pardo, J; Sosa, Y. E; Reggiani, P. C; Arciniegas, M. L; Sánchez, F; Goya, R. G.
ActaBioqClinLatinoam. 47 (2): 399-406 (2013) por parte de la Asociación de Prensa Científica de la República Argentina, para su publicación en un número especial, dedicado a la difusión de los diez trabajos científicos argentinos más destacados del año 2014, de edición binacional portugués-español del Acta Bioquímica Clínica Latinoamericana.

“Profesor Dr. Samuel M. Mc Cann 2007”
Otorgado por la Sociedad Argentina de Fisiología en el marco de la Reunión 2007, realizada conjuntamente con las Sociedades Argentinas de Investigación clínica e Inmunología. Mar del Plata, 24 de noviembre de 2007.
Otorgado según el dictamen del jurado, al mejor trabajo sobre Neuroinmunoendocri- nología, titulado: Terapia génica neonatal para el péptido tímico timulina como estrategia preventiva de las alteraciones ováricas en el ratón congenitamenteatímico.
Reggiani, P. C; Barbeito, C. G; Flamini, M. A; Cónsole , G.M; Rodríguez, S. S, Dardenne, M; Goya, R. G.

“Profesor Doctor Manuel Litter”
Otorgado por la Asociación Médica Argentina y la Sociedad Argentina de Farmacología y Terapéutica. Buenos Aires, 5 de noviembre de 2007.
Al mejor trabajo científico titulado: Restauración de de la función reproductiva en ratones inmunodeficientes por medio de terapia génica con el gen del péptido timulina.
Reggiani, P. C; Martínez, E.V; Camihort, G. A; Luna, G. C; Brown, O. A; Goya, R. G; Cónsole, G. M.




I may be interested in visiting other lines of research

arrow_upward